NCT06018688 2023-09-21Osimertinib Combined With Aspirin Neoadjuvant Therapy for Resectable EGFR Mutated NSCLC Patients.Daping Hospital and the Research Institute of Surgery of the Third Military Medical UniversityPhase 2 Not yet recruiting44 enrolled